Search

The aging process significantly impacts lung physiology and is a major risk factor for chronic respiratory diseases, including chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), asthma, and non-IPF interstitial lung fibrosis. This narrative clinical review explores the molecular and biochemical hallmarks of aging, such as oxidative stress, telomere attrition, genomic instability, epigenetic modifications, proteostasis loss, and impaired macroautophagy, and their roles in lung senescence. Central to this process are senescent cells, which, through the senescence-associated secretory phenotype (SASP), contribute to chronic inflammation and tissue dysfunction. The review highlights parallels between lung aging and pathophysiological changes in respiratory diseases, emphasizing the role of cellular senescence in disease onset and progression. Despite promising research into modulating aging pathways with interventions like caloric restriction, mTOR inhibitors, and SIRT1 activators, clinical evidence for efficacy in reversing or preventing age-related lung diseases remains limited. Understanding the interplay between aging-related mechanisms and environmental factors, such as smoking and pollution, is critical for developing targeted therapies. This review underscores the need for future studies focusing on therapeutic strategies to mitigate aging's detrimental effects on lung health and improve outcomes for patients with chronic respiratory conditions. [ABSTRACT FROM AUTHOR]

Sarcoidosis, an enigmatic disease with unknown etiology, is characterized by inflammation and the potential involvement of various organs, predominantly the lungs and intrathoracic lymph nodes. Non-caseating granulomas can resolve spontaneously in approximately 60% of cases within 2-3 years. However, sarcoidosis-related mortality has increased. Lung fibrosis, affecting up to 20% of sarcoidosis patients, stands out as a primary cause of mortality. Traditionally, fibrosis is viewed because of prolonged inflammation, necessitating antiinflammatory treatment with systemic steroids, immunosuppressants, and anti-TNF agents to manage the disease. The recent introduction of antifibrotic drugs such as nintedanib and pirfenidone offers new avenues for treating fibrotic sarcoidosis. Nintedanib, effective in idiopathic pulmonary fibrosis (IPF) and systemic sclerosis-related interstitial lung disease (SSc-ILD), has shown promise in patients with various progressive fibrosing interstitial lung diseases (PF-ILD), including those with sarcoidosis. Pirfenidone, also effective in IPF, has demonstrated potential in managing fibrotic sarcoidosis, though results have been inconclusive due to limited participant numbers in studies. This review explores the theoretical and empirical evidence supporting the use of antifibrotics in sarcoidosis, weighing the benefits and drawbacks. While antifibrotics offer a potential therapeutic approach, further randomized controlled trials are essential to determine their efficacy in fibrotic sarcoidosis. Addressing fibrosis as a continuum of chronic inflammation, the role of antifibrotics in managing sarcoidosis remains an area requiring more in-depth research to improve patient outcomes and advance treatment paradigms. [ABSTRACT FROM AUTHOR]

Background: Exacerbation of chronic obstructive pulmonary disease (ECOPD) significantly impact health status, hospitalization rates, and disease progression, and are linked to increased mortality. Predictive factors for ECOPD are therefore of considerable interest. The limited understanding of interleukin 16 (IL-16) and IL-25 role in ECOPD provided the rationale for this study. Methods: Fifty ex-smokers diagnosed with COPD (22 ECOPD and 28 patients in the stable phase of the disease) underwent prospective analysis to evaluate the role of I IL-25 as predictive markers of clinical outcomes in ECOPD. Results: We observed a significantly lower IL-16 and higher IL-25 concentrations among ECOPD patients (p = 0.002 and p = 0.01 respectively). We also detected a significant negative correlation between IL-16 and neutrophil-to-lymphocyte ratio (NLR) (p = 0.04) and a significant negative correlation between IL-25 concentration and absolute eosinophil count (p = 0.04). In the entire group, we observed a positive correlation between IL-16 and both FEV1 and FVC, both expressed as a percentage of reference value, (p = 0.002 and p = 0.0004 respectively). However, after stratification to ECOPD and stable COPD group, significance maintained for FVC (p = 0.045 for ECOPD and p = 0.02 for stable COPD). In survival analysis, we detected significantly lower all-cause mortality for 3rd tertile of IL-16 concentrations, with a hazard ratio of 0.33 (95%CI: 0.11–0.98; p = 0.04). Conclusions: Lower IL-16 levels among ECOPD patients may indicate a feedback mechanism linked to heightened Th1 response activation. Observed correlations with ventilatory parameters and survival also seems to reflect this mechanism. The higher IL-25 concentrations observed in ECOPD patients, along with the negative correlation with absolute eosinophil count and eosinopenia, suggest multifactorial regulation and independent functions of eosinophils and IL-25. Hypothetically, this paradox may be related to the Th1/Th2 imbalance favoring Th1 response. Obtained results should be reproduced in larger size samples. [ABSTRACT FROM AUTHOR]

Background: Dyspnea commonly stems from combined myocardial and pulmonary dysfunction, posing challenges for accurate pre-hospital diagnosis. Limited diagnostic capabilities hinder the differentiation of cardiac and pulmonary issues. This study assesses the efficacy of combined cardiac and pulmonary ultrasound using the BLUE, eFAST, and FATE protocols. Methods: Participants were consecutively enrolled from dyspnea-related emergency calls in Warsaw, Poland, from 4 April 2022, to 15 June 2023. Patients with pleural effusion were identified through pre-hospital and in-hospital radiological assessments. Pre-hospital thoracic ultrasonography followed the BLUE, eFAST, and FATE protocols, alongside comprehensive clinical assessments. The pre-hospital diagnoses were juxtaposed with the with hospital discharge diagnoses. Results: Sixteen patients (8 men, 8 women; median age: 76 years) were enrolled. Inter-rater agreement for the BLUE protocol was substantial (κ = 0.78), as was agreement for eFAST (κ = 0.75), with almost perfect agreement for combined protocol assessment (κ = 0.83). Left ventricle hypokinesis, identified via the FATE protocol, significantly correlated with hospital-diagnosed decompensated heart failure as the primary cause of dyspnea. Sensitivity and specificity were 1.0 (95%CI: 0.62–1.0) and 0.6 (95%CI: 0.15–0.95), respectively. Positive predictive value was 0.85 (95%CI: 0.55–0.98), and diagnostic accuracy was 0.86 (95%CI: 0.62–0.98). Conclusions: Integrating the FATE protocol into BLUE and eFAST enhances pre-hospital differential diagnosis accuracy of pleural effusion in adults. This synergistic approach streamlines diagnostic processes and facilitates informed clinical decision-making. Larger-scale validation studies are needed for broader applicability. [ABSTRACT FROM AUTHOR]

Enabling remote and temperature‐independent pressure sensing based on luminescence kinetics holds significant potential for the development of a luminescence pressure sensor with a wide array of applications. To meet these requirements, in this work, a unique lifetime‐based luminescence manometer is demonstrated for which an increase in pressure results in an elongation of lifetime of 2E state of Mn4+ due to a change in the probability of radiative depopulation of the 2E level of Mn4+ ions with an unprecedentedly high sensitivity of 35% GPa−1. Furthermore, the pressure‐induced modification in the covalency of the Mn4+─O2− bond facilitates a manometer operating in spectral band shift and ratiometric modes with sensitivities of 26 cm−1 GPa−1 (1.2 nm GPa−1) and 24.8% GPa−1, respectively. This study firmly supports the belief that the distinct pressure‐dependent kinetics governing the depopulation of Mn4+ ions at the 2E level, along with the resulting advantageous manometric performance, will pave the way for a new research trajectory in luminescence manometry. [ABSTRACT FROM AUTHOR]

Enabling remote and temperature‐independent pressure sensing based on luminescence kinetics holds significant potential for the development of a luminescence pressure sensor with a wide array of applications. To meet these requirements, in this work, a unique lifetime‐based luminescence manometer is demonstrated for which an increase in pressure results in an elongation of lifetime of 2E state of Mn4+ due to a change in the probability of radiative depopulation of the 2E level of Mn4+ ions with an unprecedentedly high sensitivity of 35% GPa−1. Furthermore, the pressure‐induced modification in the covalency of the Mn4+─O2− bond facilitates a manometer operating in spectral band shift and ratiometric modes with sensitivities of 26 cm−1 GPa−1 (1.2 nm GPa−1) and 24.8% GPa−1, respectively. This study firmly supports the belief that the distinct pressure‐dependent kinetics governing the depopulation of Mn4+ ions at the 2E level, along with the resulting advantageous manometric performance, will pave the way for a new research trajectory in luminescence manometry. [ABSTRACT FROM AUTHOR]

The blackcurrant gall mite (Cecidophyopsis ribis) is the most important pest of blackcurrant crops. Over recent years withdrawal from plant protection programmes of chemical products (endosulfan and amitraz) used for the control of this pest in Poland, has led to an observed increase in population numbers. In 2013, fenpiroxymate (Ortus 05 SC) became registered for control of this pest. It is deemed best that chemical protection should be used during the migration period; when big gall mites emerge from buds in search of new buds. The studies were carried out in a plantation of blackcurrants during 2011-2013. The assessment of migration of the blackcurrant gall mite was carried out on the cultivars ‘Ben Hope’, ‘Ben Alde’r, ‘Ojeby’n and ‘Ruben’. Every year, from selected cultivars buds were collected. They were then placed on blackcurrant leaves within Petri dishes. After one, three and five days of placing buds on the leaves, the estimated number of eriophyid mites on the leaves was calculated. The data has shown a very useful method for monitoring blackcurrant gall mite, which can be used in calculating the treatment dates for this pest. Also, the data has shown that differences in the periods of migration of the mite are dependent on the cultivar and time of flowering. Among the cultivars observed the least susceptible to colonization by the blackcurrant gall mite was a Polish cultivar ‘Ruben’, while the most susceptible cultivar was ‘Ben Hope’.